Back
Cellectis SA 10K Form
Buy
53
CLLS
Cellectis SA
Last Price:
$4.85
Seasonality Move:
-0.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLLS News And Ratings
See the #1 stock for the next 7 days that we like better than CLLS
CLLS Financial Statistics
Sales & Book Value
| Annual Sales: | $41.4M |
|---|---|
| Cash Flow: | $-4M |
| Price / Cash Flow: | 12.03 |
| Annual Sales: | $1.00 |
| Price / Book: | 4.65 |
Profitability
| EPS (TTM): | -0.33320 |
|---|---|
| Net Income (TTM): | $-35.7M |
| Gross Margin: | $21.6M |
| Return on Equity: | -31.08% |
| Return on Assets: | -9.65% |
Cellectis SA Earnings Forecast
Key Cellectis SA Financial Ratios
-
The Gross Profit Margin over the past 18 years for CLLS is 52.12%.
-
The Selling, General & Administrative Expenses for CLLS have been equal to 45.98% of Gross Profit Margin.
-
The Research & Development expenses have been 173.82% of Revenue.
-
The Net Earning history of CLLS is -88.57% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 7 years.
Cellectis SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLLS |
| CUSIP: | 15117K |
| Website: | cellectis.com |
Debt
| Debt-to-Equity Ratio: | 1.19 |
|---|---|
| Current Ratio: | 1.49 |
| Quick Ratio: | 1.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLLS Technical Analysis vs Fundamental Analysis
Buy
53
Cellectis SA (CLLS)
is a Buy
Is Cellectis SA a Buy or a Sell?
-
Cellectis SA stock is rated a BuyThe current Cellectis SA [CLLS] share price is $4.83. The Score for CLLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.